Drug intelligence / Profile preview

trigonella foenum-graecum (Universitas Indonesia)

Development stage: Unknown
Lead developer: Specnova
Administration: Topical

Overview

*Trigonella foenum-graecum*, commonly known as fenugreek, is a botanical extract being investigated for its phytoestrogenic properties in dermatological applications. In the context of post-menopausal skin aging, the extract is formulated as a topical cream to address hypoestrogenism-related skin changes. It is thought to modulate skin physiology by stimulating the expression of Type I and Type III collagen (COL1A1 and COL3A1), thereby increasing skin thickness and reducing the appearance of wrinkles. The development for this specific indication is led by researchers at Universitas Indonesia.

Other names: fenugreektrigonella foenum-graceum

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on trigonella foenum-graecum (Universitas Indonesia).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on trigonella foenum-graecum (Universitas Indonesia).

Explore the full profile